Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV) 2020: Industry and Pipeline Assessment - ResearchAndMarkets.com

The "Relapsed/Refractory (R/R) Epstein-Barr virus (EBV) - Pipeline Insight, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.